Archive · 3 Sep 2025
Welcure Drugs to Get Investment from Telexcell Trade
Welcure Drugs & Pharmaceuticals is getting an investment.
A Singapore-based company, Telexcell Trade Pte, plans to buy 25% of Welcure.
They will pay cash for this.
Both companies have agreed, but there are still some steps to take.
They need to check everything carefully and get approvals.
If all goes well, it should be finalized in three months.
This investment aims to help Welcure grow and sell more of its products in new markets around the world.
Welcure Drugs & Pharmaceuticals executed a Letter of Intent with Telexcell Trade Pte.
Telexcell Trade Pte will buy a 25% equity stake in Welcure Drugs.
The indicative price per share is ₹20.
The investment is an all-cash deal.
The deal requires approvals from regulatory bodies.
- Who
- Welcure Drugs & Pharmaceuticals and Telexcell Trade Pte
- What
- Telexcell Trade Pte will acquire a 25% equity stake in Welcure Drugs
- When
- Published on September 3, 2025
- Where
- N/A
- Why
- To enhance Welcure's global footprint and leverage opportunities in emerging markets.
- Company
- Welcure Drugs & Pharmaceuticals
- Acquiring Company
- Telexcell Trade Pte, Singapore
- Stake Acquisition
- 25%
- Investment Type
- Cash
- Price Per Share
- ₹20
- LOI Completion
- Within 90 days
